Acta Pharmaceutica Sinica B (Apr 2024)

A novel deep generative model for mRNA vaccine development: Designing 5′ UTRs with N1-methyl-pseudouridine modification

  • Xiaoshan Tang,
  • Miaozhe Huo,
  • Yuting Chen,
  • Hai Huang,
  • Shugang Qin,
  • Jiaqi Luo,
  • Zeyi Qin,
  • Xin Jiang,
  • Yongmei Liu,
  • Xing Duan,
  • Ruohan Wang,
  • Lingxi Chen,
  • Hao Li,
  • Na Fan,
  • Zhongshan He,
  • Xi He,
  • Bairong Shen,
  • Shuai Cheng Li,
  • Xiangrong Song

Journal volume & issue
Vol. 14, no. 4
pp. 1814 – 1826

Abstract

Read online

Efficient translation mediated by the 5′ untranslated region (5′ UTR) is essential for the robust efficacy of mRNA vaccines. However, the N1-methyl-pseudouridine (m1Ψ) modification of mRNA can impact the translation efficiency of the 5′ UTR. We discovered that the optimal 5′ UTR for m1Ψ-modified mRNA (m1Ψ–5′ UTR) differs significantly from its unmodified counterpart, highlighting the need for a specialized tool for designing m1Ψ–5′ UTRs rather than directly utilizing high-expression endogenous gene 5′ UTRs. In response, we developed a novel machine learning-based tool, Smart5UTR, which employs a deep generative model to identify superior m1Ψ–5′ UTRs in silico. The tailored loss function and network architecture enable Smart5UTR to overcome limitations inherent in existing models. As a result, Smart5UTR can successfully design superior 5′ UTRs, greatly benefiting mRNA vaccine development. Notably, Smart5UTR-designed superior 5′ UTRs significantly enhanced antibody titers induced by COVID-19 mRNA vaccines against the Delta and Omicron variants of SARS-CoV-2, surpassing the performance of vaccines using high-expression endogenous gene 5′ UTRs.

Keywords